ArticlePsychopharmacology2015

In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.

Prabhat Singh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.